http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114002433-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-786 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-581 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-9486 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54306 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-31 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-31 |
| filingDate | 2021-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114002433-B |
| titleOfInvention | Detection kit for detecting metabolic capability of aspirin and preparation method thereof |
| abstract | The invention discloses a detection kit for detecting aspirin metabolic capability and a preparation method thereof, wherein the kit comprises an elisa plate coated by a monoclonal antibody of 11-dehydrothromboxane B2, an 11-dehydrothromboxane B2 competitive product, a chromogenic substrate, a stop solution and an 11-dehydrothromboxane B2 standard solution, the monoclonal antibody of 11-dehydrothromboxane B2 is a murine monoclonal antibody, the light chain variable region sequence of the murine monoclonal antibody is shown as a sequence table SEQ ID NO.2, and the heavy chain variable region sequence of the murine monoclonal antibody is shown as a sequence table SEQ ID NO. 4. The invention adopts the enzyme-linked immunoassay kit and the method thereof, has the characteristics of accuracy, high sensitivity and the like for detecting aspirin metabolism so as to judge whether a patient has aspirin resistance or resistance, is not easily influenced by biochemical indexes such as creatinine and the like, and can greatly reduce the problem that the anti-platelet aggregation treatment fails or has poor effect caused by aspirin resistance of clinical patients. |
| priorityDate | 2021-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 214.